A Randomised, Double-Blind, Vehicle Controlled, Single Center, Parallel Group, Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore Sufferers.
Phase of Trial: Phase IV
Latest Information Update: 06 Nov 2012
At a glance
- Drugs Penciclovir (Primary)
- Indications Herpes labialis
- Focus Therapeutic Use
- Sponsors Novartis
- 09 Dec 2009 Planned end date changed from 1 Nov 2009 to 1 Mar 2010 as reported by ClinicalTrials.gov.
- 04 Dec 2009 Actual patient number (126) added as reported by ClinicalTrials.gov.
- 14 Jan 2009 New trial record.